Datwyler Opens Production Hub in Middletown, Delaware
10/01/2018
Construction of the Middletown facility started in December 2016. Since then, Datwyler invested more than $100 million in building the industry's most advanced production facility of its kind in the United States. The new site will provide jobs for approximately 120 employees. The facility is expected to be fully operational by the end of this year, with first samples to be expected in the fourth quarter of 2018.
According to company officials, with this new plant, Datwyler further strengthens its position in the U.S. pharmaceutical market, the largest pharma market worldwide. The local presence enables Datwyler to optimize its supply chain and provide customers in the region with locally produced components of the highest quality, while simultaneously ensuring business continuity.
In Middletown, Datwyler said it has taken cleanroom production to the next level and set new standards. The facility features cutting-edge production technologies and top-of-the-line equipment. Since human interaction can bear risks of contamination, Datwyler is constantly working towards increasing the degree of automation within the cleanroom.
Therefore, the individual production lines in the cleanroom are specially designed to run predominantly along the most advanced, fully automated processes. Middletown currently features the highest level of automation within the cleanroom environment out of all of Datwyler's First Line aligned facilities.
With the start of First Line production in Middletown, Datwyler further expands its presence and resources in the largest pharmaceutical market worldwide. First Line is Datwyler's most advanced state-of-the-art manufacturing concept for high-quality elastomer components for the fast-growing global biotech and pharmaceutical markets.
With the latest addition in Middletown, Delaware, Datwyler will be able to increase its global First Line production by 50 percent by 2020. Datwyler's two other facilities with First Line standard are located in Alken, Belgium, and Pune, India, enabling the company to cater to all major healthcare markets in Europe, the Asia Pacific region, and the Americas.
To reduce the risk of bio-contamination through human interaction even further, Datwyler reports it only allows few authorized personnel to enter the cleanroom environment. However, to give customers and partners the opportunity to observe the production without having to enter the cleanroom, Datwyler built an entire visitor center adjacent to the production facility. From there, visitors can learn more about the First Line concept and the individual production steps, observe the production process, and experience the uniqueness of this manufacturing approach.
Article Discussion
Most Read
-
-
A Site Selector’s Checklist for Locating in the U.S.
Location USA 2019
-
What Should High-Growth Companies Look for in a Community?
Q4 2019
-
Where to Invest in the Booming Aerospace Manufacturing Industry
2019 Auto/Aero Site Guide
-
A Changing Food Manufacturing Industry
2017 Food Processing
-
33rd Annual Corporate Survey & the 15th Annual Consultants Survey
Q1 2019
-
The Trade War and Its Impact on the Location Decision Process
Q4 2019